SG11202012592WA - Using alternating electric fields to increase permeability of the blood brain barrier - Google Patents

Using alternating electric fields to increase permeability of the blood brain barrier

Info

Publication number
SG11202012592WA
SG11202012592WA SG11202012592WA SG11202012592WA SG11202012592WA SG 11202012592W A SG11202012592W A SG 11202012592WA SG 11202012592W A SG11202012592W A SG 11202012592WA SG 11202012592W A SG11202012592W A SG 11202012592WA SG 11202012592W A SG11202012592W A SG 11202012592WA
Authority
SG
Singapore
Prior art keywords
electric fields
brain barrier
blood brain
alternating electric
increase permeability
Prior art date
Application number
SG11202012592WA
Inventor
Carsten Hagemann
Mario Lohr
Almuth F Kessler
Malgorzata Burek
Carola Forster
Catherine BRAMI
Hadas Sara Hershkovich
Tali VOLOSHIN-SELA
Original Assignee
Carsten Hagemann
Mario Lohr
Almuth F Kessler
Malgorzata Burek
Carola Forster
Catherine BRAMI
Hadas Sara Hershkovich
Voloshin Sela Tali
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carsten Hagemann, Mario Lohr, Almuth F Kessler, Malgorzata Burek, Carola Forster, Catherine BRAMI, Hadas Sara Hershkovich, Voloshin Sela Tali filed Critical Carsten Hagemann
Publication of SG11202012592WA publication Critical patent/SG11202012592WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37211—Means for communicating with stimulators
    • A61N1/37217—Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0092—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36002—Cancer treatment, e.g. tumour
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/3603—Control systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/0007—Special media to be introduced, removed or treated introduced into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/054—General characteristics of the apparatus combined with other kinds of therapy with electrotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0693—Brain, cerebrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2250/00—Specially adapted for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Psychology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Social Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Developmental Disabilities (AREA)
  • Biochemistry (AREA)
SG11202012592WA 2018-08-23 2019-08-22 Using alternating electric fields to increase permeability of the blood brain barrier SG11202012592WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862722100P 2018-08-23 2018-08-23
PCT/IB2019/057091 WO2020039390A1 (en) 2018-08-23 2019-08-22 Using alternating electric fields to increase permeability of the blood brain barrier

Publications (1)

Publication Number Publication Date
SG11202012592WA true SG11202012592WA (en) 2021-01-28

Family

ID=68104708

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202012592WA SG11202012592WA (en) 2018-08-23 2019-08-22 Using alternating electric fields to increase permeability of the blood brain barrier

Country Status (16)

Country Link
US (4) US11400269B2 (en)
EP (5) EP3892219B1 (en)
JP (1) JP6974671B2 (en)
KR (2) KR20240042240A (en)
CN (6) CN112469352B (en)
AU (2) AU2019324585C1 (en)
BR (1) BR112020025422A2 (en)
CA (2) CA3100817A1 (en)
DK (3) DK3804648T3 (en)
ES (3) ES2911526T3 (en)
HU (3) HUE056950T2 (en)
IL (1) IL279466A (en)
MX (1) MX2020013519A (en)
PL (3) PL3773291T3 (en)
SG (1) SG11202012592WA (en)
WO (1) WO2020039390A1 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10779875B2 (en) 2013-05-06 2020-09-22 Novocure Gmbh Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment
US10188851B2 (en) 2015-10-28 2019-01-29 Novocure Limited TTField treatment with optimization of electrode positions on the head based on MRI-based conductivity measurements
US10821283B2 (en) 2016-04-04 2020-11-03 Novocure Gmbh Reducing motility of cancer cells using tumor treating fields (TTFields)
US10441776B2 (en) 2016-06-30 2019-10-15 Novocure Gmbh Arrays for longitudinal delivery of TTFields to a body
CN110178029B (en) 2017-01-19 2021-11-16 诺沃库勒有限责任公司 System for observing cell cultures under a microscope while applying TTfields
JP7055906B2 (en) * 2018-07-03 2022-04-18 エドウィン・チャン Use of AC electric field to increase cell membrane permeability
US11583675B2 (en) 2018-07-10 2023-02-21 Novocure Gmbh Inhibiting viral infection using alternating electric fields
JP7233453B2 (en) * 2018-08-23 2023-03-06 ノボキュア ゲーエムベーハー Use of alternating electric fields to improve permeability of the blood-brain barrier
EP3892219B1 (en) * 2018-08-23 2022-06-01 Novocure GmbH Using alternating electric fields to increase permeability of the blood brain barrier
US11986647B2 (en) 2018-09-07 2024-05-21 Novocure Gmbh Treating autoinflammatory and mitochondrial diseases using an alternating electric field
EP3846894A1 (en) 2018-09-07 2021-07-14 Novocure GmbH Treating autoimmune diseases using an alternating electric field to reduce the proliferation of t-cells
CN112930209B (en) 2018-10-15 2024-10-15 诺沃库勒有限责任公司 Apparatus and method for generating a Tumor Treatment Field (TTFIELDS) with high uniformity throughout the brain
US11369790B2 (en) 2018-10-25 2022-06-28 Novocure Gmbh Delivering alternating electric fields (e.g., TTFields) to a subject's spinal anatomy
EP4019080A1 (en) 2018-11-19 2022-06-29 Novocure GmbH Arrays for delivering tumor treating fields (ttfields) with selectively addressable sub-elements
CN118079235A (en) 2018-11-29 2024-05-28 诺沃库勒有限责任公司 Enhanced flexibility transducer array for delivering TTField (tumor treatment field)
EP3909015B1 (en) 2019-01-08 2024-08-14 Novocure GmbH Evaluating quality of segmentation of an image into different types of tissue for planning treatment using tumor treating fields (ttfields)
JP2022522602A (en) 2019-02-26 2022-04-20 ノボキュア ゲーエムベーハー Frequency determination for TT field therapy based on electrical properties of target cancer cells
EP3954314A1 (en) 2019-02-27 2022-02-16 Novocure GmbH Delivering tumor treating fields (ttfields) using implantable transducer arrays
JP7419391B2 (en) 2019-03-29 2024-01-22 ノボキュア ゲーエムベーハー Method for restoring sensitivity to TTFields in TTFields-resistant cancer cells by PTGER3 inhibitors
EP3924039B1 (en) 2019-04-17 2023-11-22 Novocure GmbH Uploading data from an isolated system without compromising isolation
WO2021019403A1 (en) 2019-07-31 2021-02-04 Yoram Wasserman Applying tumor treating fields (ttfields) via electrodes embedded into skull implants
US11890467B2 (en) 2019-08-30 2024-02-06 Novocure Gmbh Delivering tumor treating fields (TTFields) to the neck
KR20220059958A (en) 2019-09-10 2022-05-10 노보큐어 게엠베하 A method of reducing the vitality of cancer cells by applying an alternating electric field to cancer cells and administering a checkpoint inhibitor.
DK4074367T3 (en) 2019-12-31 2023-05-22 Novocure Gmbh ARRAYS FOR DELIVERY OF TUMOR TREATMENT FIELDS (TT FIELDS) WITH INDIVIDUALLY AVAILABLE ELECTRODE ELEMENTS AND TEMPERATURE SENSORS
EP4074370A1 (en) 2019-12-31 2022-10-19 Novocure GmbH High voltage, high efficiency sine wave generator that prevents spikes during amplitude adjustments and switching of channels
CN115916325A (en) * 2020-04-24 2023-04-04 诺沃库勒有限责任公司 Increasing blood brain barrier permeability using alternating electric fields
US11818943B2 (en) 2020-06-25 2023-11-14 Novocure Gmbh Fabricating organic light emitting diodes (OLEDs) using tubulin
KR20230073173A (en) 2020-09-25 2023-05-25 노보큐어 게엠베하 Changing the metallization area of individual electrode elements in the Tumor Therapy Field (TTFIELDS) system to maximize current without overheating
JP2023553333A (en) 2020-11-25 2023-12-21 ノボキュア ゲーエムベーハー Increasing the effectiveness of the TTFIELD by applying the tumor treatment electric field (TTFIELD) at peak intensity for less than half of the time.
WO2022130183A2 (en) 2020-12-17 2022-06-23 Novocure Gmbh Pyroelectric-based temperature sensing of transducer arrays for applying tumor treating fields (ttfields)
CN113008403B (en) * 2021-02-08 2022-08-12 清华大学 Electric field generating device and temperature measuring electrode device
CN117120140A (en) * 2021-04-08 2023-11-24 诺沃库勒有限责任公司 Methods of treating neurodegenerative disorders with alternating electric fields
CN113509641A (en) * 2021-06-29 2021-10-19 北京康源嘉成生物科技有限公司 Non-pharmaceutical and non-invasive device and method for opening blood brain barrier
US20230009366A1 (en) * 2021-06-30 2023-01-12 Novocure Gmbh Using Alternating Electric Fields at Different Frequencies to Increase Permeability of the Blood Brain Barrier and also to Provide Other Benefits
JP2024533777A (en) 2021-09-30 2024-09-12 ノボキュア ゲーエムベーハー Reduction of electrical sensations in subjects treated with alternating electric fields
WO2023126842A1 (en) 2021-12-29 2023-07-06 Novocure Gmbh Apparatus for reducing electrosensation using alternating electric fields with larger cathodes and smaller anodes
WO2023126855A1 (en) 2021-12-30 2023-07-06 Novocure Gmbh Selecting values of parameters for treatment using tumor treating fields (ttfields)
US20230310877A1 (en) 2022-03-30 2023-10-05 Novocure Gmbh Reducing Electrosensation Whilst Treating a Subject Using Alternating Electric Fields by Pairing Transducer Arrays Together
IL314390A (en) 2022-03-30 2024-09-01 Novocure Gmbh Using interleaved cooling periods to increase the peak intensity of tumor treating fields
US20230398367A1 (en) 2022-06-13 2023-12-14 Novocure Gmbh Systems and methods for increasing intestinal absorption of therapeutic agents
US20230414955A1 (en) 2022-06-27 2023-12-28 Novocure Gmbh Closed-Loop Technique to Reduce Electrosensation While Treating a Subject Using Alternating Electric Fields
TW202417078A (en) 2022-06-30 2024-05-01 瑞士商諾沃庫勒有限責任公司 Electrode assembly for applying tumor treating fields (ttfields) that includes a plurality of thermally linked but electrically isolated graphite sheets
KR102637878B1 (en) * 2022-09-02 2024-02-19 주식회사 뉴로스피어 Device of brain electric field stimulation therapy using electro-fenton effects from intra-pathological lesion iron oxide crystal of neurodegenerative disease
WO2024069504A1 (en) 2022-09-30 2024-04-04 Novocure Gmbh Reducing electrosensation while treating a subject using alternating electric fields by controlling ramp-up characteristics
US20240108887A1 (en) 2022-09-30 2024-04-04 Novocure Gmbh Reducing Electrosensation While Treating a Subject Using Alternating Electric Fields by Deactivating Selected Electrode Elements
WO2024069523A1 (en) 2022-09-30 2024-04-04 Novocure Gmbh Changing the orientation of tumor treating fields (ttfields) by adjusting the amplitudes of two or more electric fields that are all in-phase with each other
US20240108699A1 (en) 2022-09-30 2024-04-04 Novocure Gmbh Compositions, systems, and methods for reducing electrosensation and/or skin irritation
US20240207604A1 (en) 2022-12-27 2024-06-27 Novocure Gmbh Multi Channel Device for Directional Shaping of Electric Fields e.g., Tumor Treating Fields (TTFields)
WO2024141897A1 (en) 2022-12-28 2024-07-04 Novocure Gmbh Positioning electrode elements on a subject's body to provide stronger alternating electric fields (e.g., ttfields) without overheating
WO2024141958A1 (en) 2022-12-29 2024-07-04 Novocure Gmbh Reducing electrosensation while treating a subject using alternating electric fields by increasing the number of steps in a ramp-up portion of a waveform
WO2024141959A1 (en) 2022-12-29 2024-07-04 Novocure Gmbh Reducing electrosensation during application of alternating electric fields by ensuring that successive increases in amplitude occur during opposite phases of an ac waveform
US20240269464A1 (en) 2023-02-10 2024-08-15 Novocure Gmbh Sequentially Positioning Sets of Electrode Arrays at Nonoverlapping Positions to Ameliorate Skin Irritation During Tumor Treating Fields (TTFields) Therapy
US20240325768A1 (en) 2023-03-31 2024-10-03 Novocure Gmbh Reducing Electrosensation When Treating a Subject Using a Rotating Alternating Electric Field by Gradually Increasing the Amplitude of the Field
WO2024201412A1 (en) 2023-03-31 2024-10-03 Novocure Gmbh Microneedles to overcome contact resistance

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1206353A (en) * 1995-11-21 1999-01-27 E·N·勒纳 Device for enhanced delivery of biologically active substances and compounds in organism
US6678558B1 (en) 1999-03-25 2004-01-13 Genetronics, Inc. Method and apparatus for reducing electroporation-mediated muscle reaction and pain response
US20030078499A1 (en) 1999-08-12 2003-04-24 Eppstein Jonathan A. Microporation of tissue for delivery of bioactive agents
US7016725B2 (en) 2001-11-06 2006-03-21 Standen Ltd. Method and apparatus for destroying dividing cells
US7146210B2 (en) 2000-02-17 2006-12-05 Standen Ltd. Apparatus and method for optimizing tumor treatment efficiency by electric fields
US8447395B2 (en) 2000-02-17 2013-05-21 Novocure Ltd Treating bacteria with electric fields
US7089054B2 (en) 2002-10-02 2006-08-08 Standen Ltd. Apparatus and method for treating a tumor or the like
US7136699B2 (en) 2002-10-02 2006-11-14 Standen, Ltd. Apparatus for destroying dividing cells
US6868289B2 (en) 2002-10-02 2005-03-15 Standen Ltd. Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor
US7599746B2 (en) * 2000-02-17 2009-10-06 Standen Ltd Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases
US8175698B2 (en) 2000-02-17 2012-05-08 Novocure Ltd. Treating bacteria with electric fields
AU3399801A (en) 2000-02-17 2001-08-27 Yoram Palti Method and apparatus for destroying dividing cells
US6546290B1 (en) * 2000-04-12 2003-04-08 Roamitron Holding S.A. Method and apparatus for electromedical therapy
US7332313B2 (en) * 2001-06-05 2008-02-19 Applied Biophysics, Inc. Electrical wounding assay for cells in vitro
US6904322B2 (en) 2002-02-15 2005-06-07 Kalaco Scientific, Inc. Transcranial electrostimulation apparatus and method
US20030171738A1 (en) 2002-03-06 2003-09-11 Konieczynski David D. Convection-enhanced drug delivery device and method of use
WO2004037341A2 (en) 2002-05-07 2004-05-06 Schroeppel Edward A Method and device for treating concer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
JP4750784B2 (en) 2004-04-23 2011-08-17 ノヴォキュアー・リミテッド Treatment of tumors by electric fields of different frequencies
DK1833552T3 (en) 2004-12-07 2010-08-02 Standen Ltd Electrodes for placing an electric field in vivo for a longer period of time
CA2594231C (en) 2004-12-27 2016-04-19 Standen Ltd. Treating a tumor or the like with electric fields at different orientations
US8788044B2 (en) 2005-01-21 2014-07-22 Michael Sasha John Systems and methods for tissue stimulation in medical treatment
US20100049117A1 (en) 2005-04-18 2010-02-25 Pantec Biosolutions Ag Microporator for Porating a Biological Membrane and Integrated Permeant Administering System
EP3804809B1 (en) * 2005-10-03 2023-12-27 Novocure GmbH Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
US8019414B2 (en) 2006-04-05 2011-09-13 Novocure Ltd. Treating cancer using electromagnetic fields in combination with other treatment regimens
DK2167194T3 (en) 2007-03-06 2017-06-19 Novocure Ltd TREATMENT OF CANCER USING ELECTROMAGNETIC FIELDS IN COMBINATION WITH PHOTODYNAMIC THERAPY
JP5485153B2 (en) 2007-08-14 2014-05-07 ノボキュア リミテッド Parasite treatment by electric field
US8715203B2 (en) 2007-09-17 2014-05-06 Novocure Limited Composite electrode
DE102008018170B4 (en) 2008-04-03 2010-05-12 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Microfluidic system and method for the construction and subsequent cultivation and subsequent investigation of complex cell arrays
US10245098B2 (en) * 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Acute blood-brain barrier disruption using electrical energy based therapy
US8926606B2 (en) 2009-04-09 2015-01-06 Virginia Tech Intellectual Properties, Inc. Integration of very short electric pulses for minimally to noninvasive electroporation
US9198733B2 (en) 2008-04-29 2015-12-01 Virginia Tech Intellectual Properties, Inc. Treatment planning for electroporation-based therapies
EP2470255A4 (en) 2009-08-24 2013-02-06 Ron L Alterman Apparatus for trans-cerebral electrophoresis and methods of use thereof
US20120310140A1 (en) 2010-12-01 2012-12-06 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
WO2013170379A1 (en) * 2012-05-13 2013-11-21 Corporation De L'ecole Polytechnique De Montreal Drug delivery across the blood-brain barrier using magnetically heatable entities
US20120323214A1 (en) 2012-05-16 2012-12-20 Totada R Shantha Alzheimer's disease treatment with multiple therapeutic agents delivered to the olfactory region through a special delivery catheter and iontophoresis
ES2898374T3 (en) * 2012-09-06 2022-03-07 Covidien Lp neurological treatment system
EP2911736A4 (en) 2012-10-25 2016-06-15 Oncosec Medical Inc Electroporation device
US9682066B2 (en) 2012-12-04 2017-06-20 University Of Cincinnati Methods of treating primary brain tumors by administering letrozole
US9655669B2 (en) 2013-05-06 2017-05-23 Novocure Limited Optimizing treatment using TTFields by changing the frequency during the course of long term tumor treatment
US10779875B2 (en) 2013-05-06 2020-09-22 Novocure Gmbh Optimizing treatment using TTfields by changing the frequency during the course of long term tumor treatment
US20180071014A1 (en) 2015-04-10 2018-03-15 Angiodynamics, Inc. System and Methods for Irreversible Electroporation with Thermally Controlled Electrodes
US11167133B2 (en) 2015-05-14 2021-11-09 London Health Sciences Centre Research Inc. Intratumoral modulation therapy
US9910453B2 (en) 2015-09-25 2018-03-06 Novocure Limited High voltage, high efficiency sine wave generator with pre-set frequency and adjustable amplitude
US10188851B2 (en) 2015-10-28 2019-01-29 Novocure Limited TTField treatment with optimization of electrode positions on the head based on MRI-based conductivity measurements
US10821283B2 (en) * 2016-04-04 2020-11-03 Novocure Gmbh Reducing motility of cancer cells using tumor treating fields (TTFields)
US10441776B2 (en) 2016-06-30 2019-10-15 Novocure Gmbh Arrays for longitudinal delivery of TTFields to a body
US20180008708A1 (en) * 2016-07-10 2018-01-11 Novocure Limited Synchronizing Tumor Cells to the G2/M Phase Using TTFields Combined with Taxane or Other Anti-Microtubule Agents
EP4218905A1 (en) 2016-08-18 2023-08-02 Novocure GmbH Temperature measurement in arrays for delivering tumour treating fields
JP7184774B2 (en) 2016-12-13 2022-12-06 ノボキュア ゲーエムベーハー Treat a patient with a TT field with electrode positions optimized using a deformable template
CN110178029B (en) 2017-01-19 2021-11-16 诺沃库勒有限责任公司 System for observing cell cultures under a microscope while applying TTfields
EP3764931A4 (en) 2018-03-12 2021-12-08 Tel Hashomer Medical Research Infrastructure And Services Ltd. Method for changing brain barrier permeability
US10953209B2 (en) 2018-03-28 2021-03-23 Board Of Regents Of The University Of Texas System Treating tumors using TTFields combined with a PARP inhibitor
CN112566665A (en) 2018-04-09 2021-03-26 莫舍·吉拉迪 Treatment of tumors with TTfields and Aurora kinase inhibitors
KR102687814B1 (en) 2018-04-10 2024-07-24 지브 봄존 Low-frequency alternating current conductivity estimates below 1 MHz obtained from two MRI images with different repetition times.
JP7055906B2 (en) 2018-07-03 2022-04-18 エドウィン・チャン Use of AC electric field to increase cell membrane permeability
US11583675B2 (en) 2018-07-10 2023-02-21 Novocure Gmbh Inhibiting viral infection using alternating electric fields
EP3892219B1 (en) * 2018-08-23 2022-06-01 Novocure GmbH Using alternating electric fields to increase permeability of the blood brain barrier

Also Published As

Publication number Publication date
ES2898090T3 (en) 2022-03-03
AU2022268405B2 (en) 2024-08-15
US20200061361A1 (en) 2020-02-27
US11351349B2 (en) 2022-06-07
IL279466A (en) 2021-01-31
PL3804648T3 (en) 2022-06-06
CN113908430A (en) 2022-01-11
EP3895643A1 (en) 2021-10-20
US11400269B2 (en) 2022-08-02
HUE056950T2 (en) 2022-03-28
CN113908433A (en) 2022-01-11
CN112469352B (en) 2021-10-08
CN113908431A (en) 2022-01-11
AU2019324585B2 (en) 2022-12-08
KR20210071964A (en) 2021-06-16
PL3892219T3 (en) 2022-10-03
CA3100817A1 (en) 2020-02-27
AU2019324585C1 (en) 2023-04-27
AU2019324585A1 (en) 2021-01-14
EP3895643B1 (en) 2023-10-11
KR102651496B1 (en) 2024-03-25
EP3878389A1 (en) 2021-09-15
JP2021522957A (en) 2021-09-02
CN113908432A (en) 2022-01-11
ES2911526T3 (en) 2022-05-19
US10967167B2 (en) 2021-04-06
KR20240042240A (en) 2024-04-01
AU2022268405A1 (en) 2023-01-05
JP6974671B2 (en) 2021-12-01
DK3804648T3 (en) 2022-04-11
NZ770867A (en) 2023-11-24
EP3773291A1 (en) 2021-02-17
EP3804648A1 (en) 2021-04-14
CA3242209A1 (en) 2020-02-27
CN112469352A (en) 2021-03-09
HUE058160T2 (en) 2022-07-28
PL3773291T3 (en) 2022-01-31
DK3892219T3 (en) 2022-06-27
ES2922576T3 (en) 2022-09-16
CN112618956A (en) 2021-04-09
EP3892219B1 (en) 2022-06-01
US20200269037A1 (en) 2020-08-27
WO2020039390A1 (en) 2020-02-27
HUE059062T2 (en) 2022-10-28
US20220265982A1 (en) 2022-08-25
BR112020025422A2 (en) 2021-03-16
US20200061360A1 (en) 2020-02-27
EP3892219A1 (en) 2021-10-13
EP3773291B1 (en) 2021-10-27
EP3804648B1 (en) 2022-01-19
DK3773291T3 (en) 2021-11-15
EP3895643C0 (en) 2023-10-11
MX2020013519A (en) 2021-05-12

Similar Documents

Publication Publication Date Title
IL279466A (en) Using alternating electric fields to increase permeability of the blood brain barrier
IL279465A (en) Using alternating electric fields to increase cell membrane permeability
IL279252A (en) Inhibiting viral infection using alternating electric fields
GB201808143D0 (en) Microfluidic model of the blood brain barrier
PL3244965T3 (en) Treatment of headaches by electrical stimulation
EP2968940A4 (en) Multi-site transcutaneous electrical stimulation of the spinal cord for facilitation of locomotion
IL262522B (en) Therapeutic neuregulin peptides for the treatment or prophylaxis of heart failure
IL246384A0 (en) Blood brain barrier shuttle
IL261224A (en) Noninvasive electric brain stimulation system
IL260349B (en) Device for non-invasive electrical stimulation of the spinal cord
GB201613187D0 (en) Blood brain barrier model
HK1256033A1 (en) Use of peptides to stimulate the immune system
EP3528765C0 (en) Therapy tape to aid patient recovery
IL259490A (en) Vaccination with mica/b alpha 3 domain for the treatment of cancer
GB2546139B (en) Improvements relating to the manufacture of medical devices
EP3058985A4 (en) Electric or magnetic stimulation device for treatment of circulatory disease
SG10201700022QA (en) Intradermal Administration Of Immunoglobulin G Preparation
HK1223280A1 (en) Human plgf-2 for the prevention or treatment of heart failure plgf-2
EP3860638A4 (en) Use of vegf at multiple doses to enhance permeability of blood brain barrier
GB201712881D0 (en) Alternate between usage of the left or right brain
GB201503818D0 (en) Non-invasive deep brain stimulation
GB201503816D0 (en) Non-invasive deep brain stimulation
TWM533345U (en) Structure improvement of electric connector
TWM533475U (en) Improved structure of filter
GB201401287D0 (en) Bernard's theory of inertia applied to the human brain